<DOC>
	<DOCNO>NCT00499954</DOCNO>
	<brief_summary>This mono-centre trial perform Center Clinical Research Medical University Graz . There screen information study visit.In study visit arterialize venous blood glucose value monitor subcutaneous sample interstitial fluid ( ISF ) microdialysis glucose determination perform . Additionally laboratory analysis subcutaneous glucose sample , glucose measure extracorporeal on-line sensor two market device ( Guardian RT Glucoday S ) .The study visit last 30 hour start insertion microdialysis catheter abdominal subcutaneous tissue insertion catheter Glucoday S system Guardian RT system . The primary hypothesis study : Interstitial fluid glucose concentration profile correlate arterialize venous blood glucose concentration profile type 1 diabetic subject .</brief_summary>
	<brief_title>Investigation Correlation Between Concentrations Glucose Blood Interstitial Fluid Type 1 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Signed informed consent obtain trialrelated activity . Skin fold thickness minimally 5 mm Age patient range 19 60 year . Type 1 diabetes Severe acute and/or chronic disease Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation . Taking vasoactive substance anticoagulation medication . Diseases skin could interfere application catheter Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>microdialysis</keyword>
	<keyword>subcutaneous adipose tissue</keyword>
	<keyword>glucose sensor</keyword>
	<keyword>glucose monitoring</keyword>
	<keyword>type 1 diabetes</keyword>
	<keyword>Guardian RT</keyword>
	<keyword>Glucoday S</keyword>
</DOC>